platinum has been researched along with Sarcoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dotsu, Y; Fukuda, M; Fukuoka, J; Gyotoku, H; Honda, N; Miyazaki, T; Mukae, H; Nakao, T; Obase, Y; Ozasa, M; Sakamoto, N; Suyama, T; Takemoto, S; Taniguchi, H; Tomohito, K; Umeyama, Y; Yamaguchi, H | 1 |
| Felley-Bosco, E; Friess, M; Frischknecht, L; Korol, D; Opitz, I; Soltermann, A; Stahel, R; Thies, S; Vrugt, B; Weder, W | 1 |
| Chen, X; Hou, S; Liu, W; Lou, L; Xie, M; Ye, Q; Yu, Y | 1 |
| Cai, S; Cohen, MS; Ehrhart, EJ; Forrest, ML; Gustafson, DL; Hansen, RJ; Venable, RO; Worley, DR | 1 |
| Dorey, F; Eckardt, J; Eilber, FC; Eilber, FR; Nelson, SD; Rosen, G; Selch, M | 1 |
| el-Yazigi, A; Kanaan, I; Martin, CR; Siqueira, EB | 1 |
6 other study(ies) available for platinum and Sarcoma
| Article | Year |
|---|---|
Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case report.
Topics: Aged; Antibodies, Monoclonal, Humanized; Humans; Immunotherapy; Lung Neoplasms; Male; Platinum; Sarcoma | 2021 |
Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Cell Adhesion Molecules; Cell Line, Tumor; Chemotherapy, Adjuvant; Cohort Studies; Deoxycytidine; Disease-Free Survival; Epithelial-Mesenchymal Transition; Female; Gemcitabine; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Nestin; Pemetrexed; Platinum; Pleural Neoplasms; Pneumonectomy; Prognosis; Sarcoma; Stem Cell Factor | 2015 |
Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Male; Mice; Mice, Inbred BALB C; Organoplatinum Compounds; Platinum; Sarcoma; Sarcoma 180 | 2008 |
Effects of intratumoral administration of a hyaluronan-cisplatin nanoconjugate to five dogs with soft tissue sarcomas.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cisplatin; Dog Diseases; Dogs; Female; Half-Life; Hyaluronic Acid; Injections, Intradermal; Lymphoscintigraphy; Male; Mass Spectrometry; Nanoconjugates; Pilot Projects; Platinum; Sarcoma | 2012 |
High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality.
Topics: Amputation, Surgical; Antineoplastic Agents; Antineoplastic Protocols; Combined Modality Therapy; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Limb Salvage; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Platinum; Prognosis; Radiotherapy; Risk Factors; Sarcoma; Survival Analysis; Treatment Outcome | 2003 |
Cerebrospinal fluid content of manganese, platinum, and strontium in patients with cerebral tumors, leukemia, and other noncerebral neoplasms.
Topics: Adolescent; Adult; Brain Neoplasms; Breast Neoplasms; Female; Humans; Lymphoma; Male; Manganese; Platinum; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reference Values; Sarcoma; Strontium | 1990 |